Trane Technologies plc
TT - NYSE - $472.24 ▲ +%2.39
-
Earnings
Thu 29 Oct
Trane opens the
books on Thursday evening.
2 analysts' median target is $555[FMP target], stock is $472, +17.5% upside potential. After Q2 +0.9% EPS beat[FMP earnings], the stock moved +3.3%.
↓
summary below
Quick Take - in 40 seconds
B
BUY
Council 3/6
-
Moonshot 51
B = MoonshotScore 51[multi-pillar formula] + Council 3/6[6-lens rule]. Commercial HVAC guidance reduction from 9% -> 10-10%[Christopher Kuehn Q-prev transcript] and the current Form 4 signal (0 transactions)[FMP Form 4] prevented an A- grade.
Q1 consensus: revenue $6.5B[FMP est], EPS $4.64[FMP est]. Christopher Kuehn lowered Commercial HVAC guidance to 10-10% (previous 9%) in the Q2 earnings call[Christopher Kuehn Q-prev transcript]. 8 consecutive quarters of beat[FMP earnings].
$4.64
EPS Estimate
Last year $2.63 - +20% YoY YoY
10%
Commercial HVAC Guidance
Previous quarter was 9%
8
Beat Streak
Expectations beaten consecutively for the last 8 quarters
Q2 EPS +0.9% beat[FMP] but the stock +3.3% D+1[FMP D+1]. Christopher Kuehn promised $79.7M CapEx + a sequential decline in Q1 during the Q2 earnings call[Christopher Kuehn capex transcript].
Commercial Hvac Growth
commercial_hvac_growth
Americas Commercial HVAC bookings reached an all-time high, up 50% year-over-year, with broad-based growth across 11 of 14 verticals, including double-digit growth in most of them, beyond just data centers.
"Our commercial HVAC businesses delivered outstanding performance, particularly in the Americas, where bookings reached an all-time high up 50% year-over-year. ... we track 14 different verticals. They were all very strong. They were all up in fact, they were all of them up over 20%. But it's probably more constructive to look year-to-date -- and year-to-date, we had growth in 11 of 14 verticals from an order standpoint. And most of those 11 were double-digit growth."
- David Regnery, Chair and CEO - Q2 FY26 Earnings Call - July 30, 2026
$2.8 billion
Risk Indicator
Capital Allocation Capex
capital_allocation_capex
Trane Technologies maintains a balanced capital allocation strategy with a target deployment of $2.8 billion to $3.3 billion for 2026, which includes expected CapEx of 2% to 3% of revenue.
"We remain on track with our balanced capital allocation strategy with a target deployment of $2.8 billion to $3.3 billion for the year. ... We continue to pursue disciplined M&A and are strategically investing in capacity to support future growth. with expected CapEx of 2% to 3% of revenue in 2026."
- Christopher Kuehn, Executive Vice President and CFO - Q2 FY26 Earnings Call - July 30, 2026
Full Year Guidance Raise
full_year_guidance_raise
The company is raising its full year organic revenue growth outlook to approximately 9% and adjusted EPS guidance to a range of $15.20 to $15.30, reflecting strong execution and market dynamics.
"For the full year, we are again raising our guidance. This reflects the market dynamics and investment priorities we've discussed and consistent strong execution of our value creation flywheel. We are increasing our full year organic revenue growth outlook to approximately 9% and our adjusted EPS guidance to a range of $15.20 to $15.30."
- Christopher Kuehn, Executive Vice President and CFO - Q2 FY26 Earnings Call - July 30, 2026
$6 billion
Investor Focus
Capacity Supply Chain
capacity_supply_chain
The company has expanded its applied capacity 4x over the last 3 years and continues brick-and-mortar investments to meet increasing demand, actively managing supply chain constraints through robust processes and partner collaboration.
"Look, we have about $6 billion of the backlog, that's for 2027, as I said earlier. So that's going to give us a lot of momentum going into next year. We're not turning away orders, okay? We kind of I think I mentioned probably 2 quarters ago, we've expanded our applied capacity 4x over the last 3 years. That expansion continues to happen. So we have several -- first of all, we deploy our lean principles. So we're always looking to do more with what we have. But with that said, we also have brick-and-mortar investments that we're making -- we talked about Scalar already. We also have in Grand Rapids, we're making some investments. So look, that's going to continue. We're in front of that. So I feel like we're in a good spot there from a -- do we have enough capacity for the orders that are out there. And bring on if you have any orders and then just bring them out."
- David Regnery, Chair and CEO - Q2 FY26 Earnings Call - July 30, 2026
Record Backlog Visibility
record_backlog_visibility
The company expects accelerating revenue in the second half of 2026 and a strong foundation for 2027 and beyond, with a record backlog of $12.1 billion, up 70%, and $6 billion slated for future years.
"Enterprise organic bookings were up 37%, driving record backlog of $12.1 billion, up 70% year-over-year. Our exceptional bookings, record backlog and healthy pipeline provides strong visibility to accelerating revenue in the second half. Our historic backlog also lays a strong foundation for continued market outperformance in the future. with approximately $6 billion slated for 2027 and beyond."
- David Regnery, Chair and CEO - Q2 FY26 Earnings Call - July 30, 2026
Americas Transport Recovery
americas_transport_recovery
The Americas transport market is expected to improve in late 2026, leading into a multiyear up cycle, transitioning from a headwind to a healthy growth contributor for the company's portfolio.
"Following a prolonged downturn, we see the Americas transport market improving in late 2026 leading into a multiyear up cycle. Our internal outlook is directionally aligned with ACT, but assumes a more gradual slope of recovery. This reflects a more realistic pace for trailer OEMs to ramp capacity, a dynamic that has historically extended the duration of the up cycle. Having managed the down cycle effectively, while outperforming the markets. We look forward to this business transitioning from a headwind to a healthy growth contributor for our portfolio."
- David Regnery, Chair and CEO - Q2 FY26 Earnings Call - July 30, 2026
Stock Expert AI - Methodology
Do our scoring pillars, 7 perspectives, and Munger lens point in the same direction?
MoonshotScore
51 / 100
multi-pillar methodology. Cash Runway and Price Momentum strong. Operating Leverage weak.
How is it calculated? ->
Revenue Growth5.0
Q2 vs Q3: healthy growth (+10.6%)
Gross Margin4.0
Q2: average margin (35.6%)
Operating Leverage2.0
op margin healthy (19.3%)
Cash Runway10.0
FCF very strong ($1.2B, 15.0x CapEx)
R&D Intensity3.0
low R&D investment (0.0%, weak innovation)
Price Momentum7.0
RSI 51.3 balanced, 50d above
News Sentiment5.0
majority buy (54%)
Council Score
3 / 6 Bullish
6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 0 bearish (none), 3 neutral (Jim Simons, Klarman, Munger).
How is it calculated? ->
Ray Dalio macro - target upside +17.5%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 51
Klarman value - target upside +17.5%
Buffett quality - ROE score 5/5
Munger valuation - target upside +17.5%
Munger's Mindset character & balance sheet lens
Fairly Valued
Quality business, trading at fair value.
How is it calculated? ->
Interest CoverageAdequate
Technical Levels - Pre-earnings positioning
What levels is the stock being tested at?
RSI(14)
51.3
RSI 51.3 balanced, 50d above
MACD
+0.40
price above 50d - support positive
50d MA
$470
stock 0.4% above - short-term support
200d MA
$440
stock 7.3% above - long-term support
Volume (10d)
-38%
decrease - low participation
Resistance
$555
Analyst median target - upgrade trigger if broken
Current
$472
Pre-earnings position
Support
$374
Invalidation - close below this is a technical breakdown
Pattern
Range
$374-$555 band - earnings breakout/breakdown trigger
Past Performance
Trane beat expectations in the last 8 quarters.
BEAT
Q3 FY25
$3.88 vs $3.80 est - +0.5%
BEAT
Q4 FY25
$2.86 vs $2.81 est - -1.3%
BEAT
Q1 FY26
$2.63 vs $2.53 est - -1.2%
BEAT
Q2 FY26
$4.31 vs $4.27 est - +3.3%
Q2 (July 30, 2026): EPS $4.31 vs $4.27 est[FMP], +0.9% beat. D+1 movement: +3.3%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.
Three scenarios: what could happen?
Commercial HVAC below 35%
Q2: EPS $4.31 vs $4.27 beat[FMP], stock +3.3% D+1[FMP]. Christopher Kuehn Q2 transcript: "For the third quarter, we expect organic revenue growth of approximately 10% and with adjusted EPS of approximately $4.70."[Christopher Kuehn].
"For the third quarter, we expect organic revenue growth of approximately 10% and with adjusted EPS of approximately $4.70."
- Christopher Kuehn, CFO - Q2 FY26 Earnings Call - July 30, 2026
Backlog concentration
No RPO/backlog concentration disclosed in Q2 earnings call.
Insider trading signal
Form 4 data is marked in the table - this page does not generate assumptions for this stock.
Our FMP plan does not provide Form 4 insider feed for this stock. This page does not generate assumptions - SEC EDGAR Form 4 can be monitored directly.
CapEx shock
Q2 CapEx $79.7M[FMP cashflow]. Q2 op margin 19.3%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.
"-"
- Christopher Kuehn, CFO - Q2 FY26 Earnings Call - July 30, 2026
Framework - Position discipline
After the data arrives: 3 scenarios, 3 windows
Not advice - a structural framework for earnings night. Decision discipline is yours.
Scenario A - Beat
Q1 EPS > $4.64 + Commercial HVAC >= 10%
Threshold: EPS > $4.64[FMP est] and Commercial HVAC >= 10%[Christopher Kuehn transcript].
Target: Break above median target $555[FMP target]; high target $585[FMP] upper bound.
Scenario B - In-Line
EPS approx $4.64 + Commercial HVAC 10-10% + CapEx promise kept
Threshold: EPS approx $4.64[FMP est], Commercial HVAC 10-10%, Q1 CapEx < $79.7M[FMP].
Target: Consolidation in the band between current $472[FMP] and median $555[FMP].
Scenario C - Miss
EPS < $4.50 or Commercial HVAC < 35% or CapEx >= $79.7M
Threshold: EPS < $4.50[FMP estx0.97] or Commercial HVAC < 35%[Christopher Kuehn guidance lower minus 2].
Target: Current $472 below SMA200 $440[FMP], if rejection continues, $374[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.
Market Outlook
What do 2 analysts say?
Wall Street Consensus
$555
12-month median target price (+17.5% upside potential)
Risk Management
$374
Invalidation level - critical support threshold
$470 - 50-day MA (above, +0.4%)
$440 - 200-day MA (above, +7.3%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - TT Q1 FY27
B
You read it in 5 minutes. When the numbers come out on Thursday evening - you know what you're looking at.
Data arrives at night. The framework is ready now.
Data arrives on Thursday evening. The framework is ready on this page: Q1 EPS threshold $4.64[FMP], Commercial HVAC guidance 10-10%[Christopher Kuehn], CapEx threshold "below $79.7M"[Christopher Kuehn]. Three anchors, three scenarios.
Comparison
Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).
3 subscriptions. 1 platform.
Seeking Alpha $299/yr - analyst opinions + earnings coverage
TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades
Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts
Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing
Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.
Educational tool, not investment advice. Past performance does not guarantee future results.
Calendar
Catalyst Calendar - 90-day forward look
Oct 29, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Oct 30, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Dec 13, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Jan 29, 2027EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)
DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.
Frequently Asked Questions
What does the TT earnings preview cover?
This Trane Technologies plc (TT) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.
What should investors watch for in TT earnings?
Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.
Where do the numbers on this page come from?
Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.
Is this a buy or sell recommendation?
No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.